Kristine Williams

Kristine Williams

Auto-generated profile, based on publicly available information

Kristine Williams

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2011 in Nature
Verified
Journal Article
Closed access
PDF file
KWKristine Williams
Kristine Williams
JCJesper Christensen
Jesper Christensen
MPMarianne Terndrup Pedersen
Marianne Terndrup Pedersen
JJJens V. Johansen
Jens V. Johansen
PCPaul A. C. Cloos
Paul A. C. Cloos
KHKristian Helin
Kristian Helin

15 May 2009 in Genes & Development
Verified
Journal Article
Closed access
PDF file
KAKarl Agger
Karl Agger
PCPaul A.C. Cloos
Paul A.C. Cloos
LRLise Rudkjær
Lise Rudkjær
KWKristine Williams
Kristine Williams
GAGitte Andersen
Gitte Andersen
KHKristian Helin
Kristian Helin
The tumor suppressor proteins p16INK4Aand p14ARF, encoded by theINK4A–ARFlocus, are key regulators of cellular senescence. The locus is epigenetically silenced by the repressive H3K27me3 mark in normally growing cells, but becomes activated in response to oncogenic stress. Here, we show that expression of the histone H3 Lys 27 (H3K27) demethylase JMJD3 is induced upon activation of the RAS–RAF signaling pathway. JMJD3 is recruited to theINK4A–ARFlocus and contributes to the transcriptional activation of p16INK4Ain human diploid fibroblasts. Additionally, inhibition of Jmjd3 expression in mouse embryonic fibroblasts results in suppression of p16Ink4aand p19Arfexpression and in their immortalization.

1 February 2013 in Molecular Cell
Verified
Journal Article
Closed access
PVPietro Vella
Pietro Vella
ASAndrea Scelfo
Andrea Scelfo
SJSriGanesh Jammula
SriGanesh Jammula
FCFulvio Chiacchiera
Fulvio Chiacchiera
KWKristine Williams
Kristine Williams
DPDiego Pasini
Diego Pasini

9 December 2011 in EMBO Reports
Verified
Journal Article
Open access
PDF file
KWKristine Williams
Kristine Williams
JCJesper Christensen
Jesper Christensen
KHKristian Helin
Kristian Helin
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

5 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KWKristine Williams
Kristine Williams
JCJesper Christensen
Jesper Christensen
JRJuri Rappsilber
Juri Rappsilber
ANAnders Lærke Nielsen
Anders Lærke Nielsen
JJJens Vilstrup Johansen
Jens Vilstrup Johansen
KHKristian Helin
Kristian Helin
The JmjC domain-containing protein JMJD3/KDM6B catalyses the demethylation of H3K27me3 and H3K27me2. JMJD3 appears to be highly regulated at the transcriptional level and is upregulated in response to diverse stimuli such as differentiation inducers and stress signals. Accordingly, JMJD3 has been linked to the regulation of different biological processes such as differentiation of embryonic stem cells, inflammatory responses in macrophages, and induction of cellular senescence via regulation of the INK4A-ARF locus. Here we show here that JMJD3 interacts with the tumour suppressor protein p53. We find that the interaction is dependent on the p53 tetramerization domain. Following DNA damage, JMJD3 is transcriptionally upregulated and by performing genome-wide mapping of JMJD3, we demonstrate that it binds genes involved in basic cellular processes, as well as genes regulating cell cycle, response to stress and apoptosis. Moreover, we find that JMJD3 binding sites show significant overlap with p53 bound promoters and enhancer elements. The binding of JMJD3 to p53 target sites is increased in response to DNA damage, and we demonstrate that the recruitment of JMJD3 to these sites is dependent on p53 expression. Therefore, we propose a model in which JMJD3 is recruited to p53 responsive elements via its interaction with p53 and speculate that JMJD3 could act as a fail-safe mechanism to remove low levels of H3K27me3 and H3K27me2 to allow for efficient acetylation of H3K27.

31 July 2022 in Journal of Biological Chemistry
Verified
Journal Article
Open access
SPSigne Schultz Pedersen
Signe Schultz Pedersen
NBNils Billestrup
Nils Billestrup
KWKristine Williams
Kristine Williams
RBRomain Barrès
Romain Barrès
NBNils Billestrup
Nils Billestrup
Cytokine-induced beta cell dysfunction is a hallmark of type 2 diabetes (T2D). Chronic exposure of beta cells to inflammatory cytokines affects gene expression and impairs insulin secretion. Thus, identification of anti-inflammatory factors that preserve beta cell function represents an opportunity to prevent or treat T2D. Butyrate is a gut microbial metabolite with anti-inflammatory properties for which we recently showed a role in preventing interleukin-1β (IL-1β)-induced beta cell dysfunction, but how prevention is accomplished is unclear. Here, we investigated the mechanisms by which butyrate exerts anti-inflammatory activity in beta cells. We exposed mouse islets and INS-1E cells to a low dose of IL-1β and/or butyrate and measured expression of inflammatory genes and nitric oxide (NO) production. Additionally, we explored the molecular mechanisms underlying butyrate activity by dissecting the activation of the nuclear factor-κB (NF-κB) pathway. We found that butyrate suppressed IL-1β-induced expression of inflammatory genes, such as Nos2, Cxcl1, and Ptgs2, and reduced NO production. Butyrate did not inhibit IκBα degradation nor NF-κB p65 nuclear translocation. Furthermore, butyrate did not affect binding of NF-κB p65 to target sequences in synthetic DNA but inhibited NF-κB p65 binding and RNA polymerase II recruitment to inflammatory gene promoters in the context of native DNA. We found this was concurrent with increased acetylation of NF-κB p65 and histone H4, suggesting butyrate affects NF-κB activity via inhibition of histone deacetylases. Together, our results show butyrate inhibits IL-1β-induced inflammatory gene expression and NO production through suppression of NF-κB activation and thereby possibly preserves beta cell function.